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Abstract
Estimating the impact of trauma treatment protocols is complicated by the
high-dimensional yet finite sample nature of trauma data collected from
observational studies. Viscoelastic assays are highly predictive measures
of hemostasis.1 However, the effectiveness of thromboelastography(TEG)
based treatment protocols has not been statistically evaluated. To con-
duct robust and reliable estimation with sparse data, we built an estimation
”machine” for estimating causal impacts of candidate variables using the col-
laborative targeted maximum loss-based estimation(CTMLE) framework.7
The computational efficiency is achieved by using the scalable version of
CTMLE such that the covariates are pre-ordered by summary statistics of
their importance before proceeding to the estimation steps.20 To extend the
application of the estimator in practice, we used super learning in com-
bination with CTMLE to flexibly choose the best convex combination of
algorithms. By selecting the optimal covariates set in high dimension and
reducing constraints in choosing pre-ordering algorithms, we are able to
construct a robust and data-adaptive model to estimate the parameter of
interest. Under this estimation framework, CTMLE outperformed the other
doubly robust estimators(IPW,AIPW,stabilized IPW,TMLE) in the simu-
lation study. CTMLE demonstrated very accurate estimation of the target
parameter (ATE). Applying CTMLE on the real trauma data, the treatment
protocol (using TEG values immediately after injury) showed significant im-
provement in trauma patient’s hemostasis status (control of bleeding), and a
decrease in mortality rate at 6h compared to standard care. The estimation
results did not show significant change in mortality rate at 24h after arrival.
1 Introduction
Globally, trauma is a leading cause of death and poses both clinical and sta-
tistical challenges.1 Using highly predictive measures to optimize treatment
assignment is of great current interest. Given the most common preventable
cause of death after trauma is bleeding, important predictor variables are
related to controlling bleeding and treating impaired coagulation that can be
diagnosed with standard plasma-based lab test like INR(International Nor-
malized Ratio)/PTT(Partial Thromboplastin Time), as well as viscoelastic
assays like TEG (Thromboelastography).2 Viscoelastic assays are used to
identify real time abnormalities of clot formation and fibrinolysis, termed
trauma-induced coagulopathy.1 However, the association of abnormalities
identified by TEG with TIC (Trauma-Induced-Coagulopathy) are incom-
pletely defined, and specifically the impact of treatment rules assigned based
on TEG measures has not been closely examined. The goal of our study
was to employ robust, semiparametric data-adaptive modeling procedures
(specifically, scalable collaborative targeted minimum loss-based estimation)
to estimate the potential impact of various protocols for achieving hemosta-
sis (control of bleeding) and avoiding death.
We focused on estimating the impact of blood products assigned based on
TEG measures on patient’s hemostasis and mortality status. Since the co-
variates are high-dimensional, we deployed ensemble machine learning (Su-
perLearning) methods for modeling the prediction of outcomes versus both
adjustment covariates and intervention variables.4 Given the common prob-
lem of high dimension and small sample, standard doubly-robust estimators
(such as estimating equation and targeted learning approaches) can break
down due to lack of experimentation in the data (positivity violations),
caused by high correlation between covariates and exposures in trauma
data.3 We developed estimators of our estimands of interest within the col-
laborative targeted minimum loss-based estimation framework(CTMLE),
which optimizes the variance-bias trade-off when modeling the so-called
propensity score, not with respect to prediction intervention, but to the
estimand/parameter of interest.7 This allows for more automated estima-
tion using machine learning in situations with limited data. Also,we built
upon the standard CTMLE framework by adding pre-ordering step to boost
the computational efficiency. CTMLE demonstrated robust and accurate
estimation to the target parameter in the simulation study compared to the
other doubly robust estimatros(IPW,AIPW,stablized IPW,TMLE). Also,
the super learner version of CTMLE (SL-CTMLE) achieved excellent com-
putational efficiency for high-dimensional adjustment sets. 20
2 Method
2.1 Data
1671 trauma patients at San Francisco General Hospital were enrolled in an
observational cohort study as part of the ongoing prospective longitudinal
examination of the activation of coagulation and inflammation after injury.
Injury, demographic, clinical and outcome data was collected on arrival and
out to 28 days for all patients. TEG parameters from the ED were solely for
study purposes and no treatment decisions were based upon their parame-
ters. Massive transfusion (MT) was defined as the transfusion of 10 units
of packed red blood cells (pRBCs)/fresh frozen plasma (FFP) in the first
24 hours, and transfusion decisions were at the discretion of the attending
trauma surgeon. Blood samples were drawn in citrated vacuum tubes upon
arrival to the ED, and then again at 6 hours. Citrate rapid thromboelas-
tography (CRT TEG) and citrated kaolin TEG (CK TEG) were performed
with the TEG 5000 immediately after sample collection. The patients were
statistically treated with blood product transfusion based on a protocol de-
fined as: 2 units of plasma for ACT(activated clotting time) > 128 seconds,
10 units of cryo (cryoprecipitate) for alpha angle< 65 degrees, and one 1 unit
of plt(platelets) for MA(maximum amplitutde) < 55mm.The demographics
and baseline measurements are summarized in Table 1.
Table 1: Baseline Covariates and Missingness
Covariates Mean(sd) Number of Missing Values(%)
(Injury Survey Score)iss 17.7(15.63) 2(0.12)
Admit base excess -4.0(6.31) 433(25.91)
Gender, n(%)
Female 310(18.55) 0(0)
Male 1361(81.45) 0(0)
Age 41(18.6) 3(0.18)
Mechanism, n(%)
Blunt 960(57.45) 5(0.30)
Penetrating 706(42.25) 0(0)
Systolic blood pressure (sbp, mmHg) 135.9(33.26) 43(2.57)
Heart rate (hr, bpm) 97.6(24.93) 42(2.51)
Race, n(%) 1(0.06)
White 949 (56.79)
Black 375 (22.44)
Asian 214(12.81)
Native American 8(0.48)
Pacific Islander 9(0.54)
Other 36(2.15)
Unknown 79(4.73)
Table 1: Summary of covariates and missingness of the data.
2.2 Estimation Problem Definition
We aimed to analyze the average treatment effect of patients being on versus
off protocol. We modeled the trauma data as following: a collection of base-
line covariates, W , containing imputed values and missingness indicators
(summarized in Table 1).
A∗j = I(dj(V )), V /∈W
Treatment was not assigned uniformly, but instead assigned by mapping
a set of continuous measures V (ACT,Alpha, MA, refer to section 3.1) to
binary indicators {1,0} (on/off protocol). dj refers to a deterministic treat-
ment assignment for each individual j (j = 1..n), as a function of continuous
measures V. The variables used to define V were excluded from the set W
to ensure the expected conditional outcome is well-defined.
Binary outcome Y represented the outcome (e.g. 6h hemostasis, 6h mor-
tality or 24h mortality) of each patient.We used notation Oi = (Wi, Ai, Yi)
to represent each observation unit. The parameter of interest is defined as:
Ψ(P0) = E0[E0(Y |A = 1,W )− E0(Y |A = 0,W )] (1)
where Ψ can be interpreted as a causal risk difference under assumptions
(W contains all confounders, there is sufficient experimentation of A within
strata of W 6, time orders of W → A→ Y ). However, it can also be thought
of more generally as a measure of importance (akin to comparing adjusted
means), without appeal to a causal model. Instead of treating the target
estimand as a causal parameter, we take a more conservative perspective by
treating the estimand as a statistical association controlling for the baseline
covariates W given in Table 1.
For future sections, we will introduce a few new notations: the treatment
model is defined as g0(a,W ) = P0(A = a|W ), the conditional mean of the
outcome is: Q¯0(A,W ) = E0(Y |A,W ). The empirical version of the above
notations are represented as: gn(A,W ) and Q¯n(A,W )
2.3 Model Trauma Data
2.3.1 Treatment Variable
The original data was a sequence of continuous measures (act,alpha, ma,refer
to section 3.1) representing the units of each blood product given to patients
from 0h to 24h. By comparing the continuous measures and predefined
protocols (cases in Algorithm 1 below), we were able to map the measures
into on/off protocol status. We examined three separate rules based upon
different sets of variables. Note, that A∗ = d(V ) could imply both A∗ = 0
or A∗ = 1, depending on what the rule indicates given the variables V . In
essence, being defined as an intervention where a subject receives a specific
level of an intervention, it means that the patient receives the treatment as
indicated by the particular rule. One could estimate a parameter equivalent
to 1, by defining A = I(A∗ = d(V )), that is the indicator of receiving the
treatment returned by rule, d(V ).
Each of the three rules investigated, d(V ), are defined as following:
Algorithm 1: Mapping continuous measures to binary on/off protocol
status
case 1
if act ≥ 128 and plasma > 0, A = 1
if act ≥ 128 and plasma = 0, A = 0
if act = 0 or act < 128 and plasma = 0, A = 1
else A = 0
case 2
if alpha ≤ 65 and cryo > 0, A = 1
if alpha ≤ 65 and cryo = 0, A = 0
if alpha = 0 and cryo = 0, A = 1
else A = 0
case 3
if ma ≤ 55 and plt > 0, A = 1
if ma ≤ 55 and plt > 0, A = 0
if ma = 0 and plt = 0, A = 1
else A = 0
2.3.2 Outcome Variable
We analyzed three different types of outcomes: 1) hemostasis 2) mortality
at 6h 3) mortality at 24h. Hemostasis is defined by whether or not the
patient received packed red blood cells(RBC) after 6h (e.g. 7-12h interval).
If the patient received treatments in 0-6h but did not receive packed RBC
in 7-12h, then hemostasis was achieved. If the patient received packed RBC
in 7-12h, hemostasis is coded as non-hemostasis. Mortality outcomes were
given in the original data (e.g. dead = 1, alive = 0).
2.3.3 Covariates
Baseline covariates used for the analysis are shown in Data section(3.1).
Only for theses variables, we imputed the missing values and also added,
for each covariate with missing values, an additional basis function as the
indicator that a particular observation had the covariate observed versus
missing. Thus, one can think of our final list of covariates, W , as the infor-
mation sufficient to consistently estimate the marginal adjusted (for all the
confounders) associations of interest.
2.4 Doubly Robust Estimators
TMLE based estimator has its root in doubly robust estimators.6 Double
Robust(DR) estimators generally refer to estimators of the target parameter
of interest that have either Q¯0 or g¯0 part or both being consistent.
8 To find
the best DR, we aim to find the estimator with efficient influence curve. The
efficient influence curve of the target parameter in a semiparametric model
model is defined as: 11
D∗(Q¯0, g0)(O) =
a
g0(1,W )
− 1− a
g0(0,W )
[Y−Q¯0(A,W )]+Q¯0(1,W )−Q¯0(0,W )−Ψ(P0)
(2)
The augumented inverse probability of treatment weighted (AIPTW)
estimator is one example of a doubly robust estimator.16 Using the propen-
sity score and conditional mean of outcome in sample gn, Q¯n to define the
sample efficient influence influence curve, we have:16
n∑
i=1
a
gn(1,W )
− 1− a
gn(0,W )
[Yi−Q¯n(Ai,Wi)]+Q¯n(1,Wi)−Q¯n(0,Wi)−Ψn (3)
By setting the equation to 0 and solve for the target parameter directly,
we get:
ΨAIPTW =
n∑
i=1
a
gn(1,W )
− 1− a
gn(0,W )
[Yi−Q¯n(Ai,Wi)]+Q¯n(1,Wi)−Q¯n(0,Wi)
(4)
However, under the AIPTW setting, the propensity score may inflate
the value of the estimator by producing estimations outside of the reality
constraints.10 This in turn, given no inherent constraints on the estimator.
Given how sensitive the estimator is to gn, particularly in small sample
sizes, one can benefit from finite sample robustness by using a substitution
(plug-in) estimator.
2.5 TMLE
Different from the AIPTW esitmator, TMLE is a plug-in estimator which
targets specifically towards the parameter of interest by first generating an
initial estimate and then fluctuating the estimator to minimize the bias-
variance tradeoff.15 The estimation procedure can be roughly divided into
two steps. The first step involves using specified confounders and inter-
vention variable of interest as regressors to get the initial expectation of
outcome, we call Q¯0n(A,W ).
15 The updating step takes both the initial pre-
dicted value as offset and the clever covariates to regress on the expected
conditional outcome. Variance can be calculated based on the efficient in-
fluence curve and confidence intervals can be constructed accordingly.15 The
detailed algorithm is shown as follwing:
Algorithm 2: TMLE Algorithm
Estimating Step:
1.Estimate initial Q¯0n
2.Estimate gn
3.Construct cleaver covariates Hn(a,W ) using formula:
Hn(a,W ) =
a
gn(1,W )
− 1− a
gn(0,W )
(5)
Targeting Step:
4.Run Yi ∼ Hn(Ai,Wi) + logit(Q¯0n(Ai,Wi)), treating the last term as
an offset in a regression.
5.Update initial estimator using n from step 4
Q¯∗n(A,W ) = expit(logit[Q¯
0
n(A,W )] + nHn(A,W ))
6.
ΨTMLE =
1
n
n∑
i=1
(Q¯∗n(1,Wi)− Q¯∗n(0,Wi))
Thus, the estimator augments the original fit of the regression model,
by including a ”clever covariate”, which optimally adjusts for any residual
confounding remaining in the original Q¯n fit and smooths the estimator suf-
ficiently so that it is asymptotically normal. However, though TMLE can
be an attractive alternative to estimating equation approaches, it still can
suffer from overfitting of gn. Fortunately, the fact that it is a maximum
likelihood-based (or minimum loss-based) procedure, one can use the likeli-
hood (or risk) in the esitmation of Q¯ to choose the model for gn, to insure
the estimator does not ”blow-up”. Generally, procedures based upon TMLE,
but using clever selection of the model for gn based upon the likelihood (or
more generally risk) are called collaborative.
2.6 Greedy CTMLE
CTMLE is motivated by the sparse data setting. When data is sparse and
lack of good support (e.g. lack of positivity),7 the efficient influence curve
can take extremely large value such that the TMLE will have non-linear
behavior. One cause for this is that confounders might be instrumental
variables, which have no impact on the outcome variable, but are highly
correlated with the intervention variable of interest.9 However, removing the
variables with prescreening procedures could hurt the asymptotic behavior
of TMLE because there exists statistically significant covariates which lie
in the noise level.7 Most prescreening procedures are based on marginal
regression, which result in a bias of the order n−1/2. 20 CTMLE does not
affect the asymptotic behavior of TMLE, as the ”full” model will be chosen
as n→∞.
CTMLE algorithm constructs a sequence of estimators gn,h, Q
∗
n,h such
that the loss functions of both gn,h, Q
∗
n,h have decreasing values when increas-
ing h. The construction of sequences uses forward greedy search.7 CTMLE
reduces the dimension of covariates that are used to construct the external
estimator gn of g0 thereby reduces the bias introduced by positivity viola-
tions, but one that avoids dropping strong confounders.9
2.7 Scalable CTMLE
The original CTMLE uses greedy approach for selecting covariates sequen-
tially. Greedy CTMLE does have robust performance 9 and the time com-
plexity of running greedy CTMLE is O(p2) when the dimension of covariates
is p.20 In addition, when the dimension of prediction basis (p) approaches to
infinity, the large time complexity could lead to memory storage issue and
slow down the computation process. We endeavored to utilize an estimator
that is both statistically and computationally robust. In this case, if the
CTMLE template is constructed by pre-ordering covariates rather than by
greedy searching, we could largely reduce the time complexity to O(p).21
Therefore, we used this scalable CTMLE to estimate the average treatment
effect based on the data modeled in sections 3.2 and 3.3.
The pre-ordering step is in between of the estimation of Q¯0 and the iter-
ative construction step of Q¯∗n,k.
20 We ordered the covariates by the relative
decrease in cross-validated risk resulting from the model fit when these vari-
ables are included in the clever covariate (5). Specifically, for each covairte
Wk as a predictor, we used logistic model to construct gn,k of g0. Then we
defined clever covarite as a function of A and Wk. Then we run regression
of Y on clever covariate and offset Q¯0(A,W ) to fit k. After defining Q¯
∗
n,k in
the standard way, we computed the empirical cross-validated loss Lk. Each
covariate will get a rank based on the increasing value of Lk.
21
After setting up the rank, we add the covariates one by one to estimate
gn,k for k-th covariate.
20 Then we followed the standard CTMLE step to
estimate Q¯kn and evaluate the empirial loss Lk of Q¯
∗
n,k. If the empirical loss
Lk decreased compared to Lk−1, we kept adding the next covariate. Oth-
erwise, we replaced Q¯n,k by Q¯
∗
n,k−1. Then we re-add the k-th covariate.
The final step was to use cross-validation to find the best estimator from
the sequence Q¯∗n,0 to Q¯∗n,p.13 The reason such a procedure leads to greater
robustness in finite samples it tends to remove covariates in the model for g
that behave like instrumental variables, in that they are very highly predic-
tive of A but of little importance in the model for Q¯. Such variables result
in very small estimated g and since g enters as an inverse in the targeted
learning update, they tend to introduce large variance to the estimator with
little bias-reduction.
2.8 Super Learner Extension of Scalable CTMLE
The pre-ordering algorithm described in the above scalable CTMLE sec-
tion used logistic model.20To further optimize the performance of scalable
CTMLE, we combined multiple ordering algorithms, each generating a unique
templates of CTMLE algorithm. Then all the CTMLE algoritms out of
mutliple ordering schemes were merged and the one with the lowest cross-
validated risk whas chosen estimator.
To combine various algorithms without bringing computational burdens,
we relied on super learning, which is an ensemble learning strategy that com-
bines algorithms in a convex manner, such that the time complexity stays
as O(p).14 The convex nature of super learner not only preserves running
time efficiency but also preserves scalability as long as each algorithm in the
learner library is scalable.14
The super learner version of scalable CTMLE is only a small extension
added to the previous algorithm. We followed (Ju, Gruber and Lendle 2016)
SL-C-TMLE framework by defining N pre-ordering schemes and for each n-
th scheme, we run the same algorithm as in scalable CTMLE. Finally, we
used cross-validation to select the best Q¯∗n out of all (n, k) combinations. 13
We derived the variance and 95% confidence interval coverage based on the
efficient influence curve.
We used (Ju 2017)CMTLE package for the analysis.21 (https://cran.
r-project.org/web/packages/ctmle/ctmle.pdf). Results can be repro-
duced from: https://github.com/WaverlyWei/TEG-CTMLE
3 Simulation
3.1 Parametric Bootstrap
To demonstrate the robust performance of SL-CTMLE under finite sample
and close to positivity violation situations, we used parametric bootstrap to
run the simulation. In parametric bootstrap, samples were drawn from a
data generating distribution that mimics the true data generating distribu-
tion. The bias estimate in parametric bootstrap is defined as: 22
ˆBiasPB(Ψˆ, Pˆ0, n) = EPˆ0Ψˆ(P
#
n )−Ψ(Pˆ0) (6)
Pˆ0 is an estimate of the true data generating distribution P0. P
#
n is
the parametric bootstrap distribution sampled from Pˆ0. Ψ(Pˆ0) is the true
parameter applied on Pˆ0.
24 In practice, since we do not know the true target
parameter applied on Pˆ0, we would replace Ψ(Pˆ0) with the estimator of the
target parameter applied on the observed data:
Ψ(Pˆ0) = Ψˆ(Pn) (7)
The parametric bootstrap simulation procedure is implemented by first es-
timating P0. P0 includes the estimation of Q0 and g0 which further breaks
down to estimation of: P0(W = w), P (A = a|W = w), P0(Y = y|A =
a,W = w). Then we generated bootstrap samples from Pˆ0. We sampled
W with random draws and generated A as gn(1|W ). We sampled Y as
Qn(Y |A,W ) + N(0, 1).Then we applied our estimator to the bootstrapped
samples P#n and computed the empirical mean across the sample estimates:
EPˆ0Ψˆ(P
#
n )
This simulated dataset consisted of W’s generated from bivariate normal
distribution. 22
W = (W1,W2),Wi ∼ N(µ,Σ)
µ1 = 1, µ2 = 2,Σ =
∣∣∣∣1 12 3
∣∣∣∣
P (A = 1|W ) = Φ(0.23 + 0.1 ∗W1 + 0.35 ∗W2)
P (Y |A,W ) = 5.5 +A+ 0.5 ∗W1 + 4.5 ∗W2 +N(0, 1)
We generated 200 parametric bootstrap samples each with 1000 obser-
bations. Then we evaluated the performance of AIPW, IPW, stablized IPW
TMLE and SL-CTMLE on the parametric bootstrap samples. The perfor-
mance of the five estimators are shown in Figure 1 and Table 2:
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Figure 1: Estimator comparison. Dashed line indicates the true ATE value.
ATE SE Bias MSE CI
AIPW 0.133 0.118 0.121 0.0286 (-0.0997, 0.364)
IPW 0.808 0.031 0.796 0.635 (0.747, 0.869)
SL-CTMLE 1.133e-3 4.76e-4 -0.012 1.44e-4 (2.00e-4,2.066e-3)
TMLE 0.125 4.75e-4 0.113 0.0128 (0.124, 0.126)
Stablized IPW 0.127 4.67e-4 0.115 0.0132 (0.124, 0.134)
Table 2: Estimator performance comparison over 200 parametric boot-
strap samples
Doubly robust estimator IPW has the largest bias but with relatively
narrow confidence interval compared to AIPW. AIPW has the largest stan-
dard error out of all five estimators. stablized IPW and TMLE has similar
estimation performance but both have larger MSE than SL-CTMLE. SL-
CTMLE has the smallest bias, variance ans MSE out of all five estimators.
The estimated value from SL-CTMLE was cloest to the true ATE.
Then we compared the time complexity of greedy CTMLE and SL-
CTMLE which has pre-ordering embedded. SL-CTMLE took less running
time than greedy CTMLE across three different magnitude of sample sizes.
The advantage of SL-CTMLE became more prominent when the data be-
came high-dimensional. When p = 100, SL-CTMLE was 10 folds faster
than greedy CTMLE. When p = 1000, SL-CTMLE was 50 folds faster than
greedy CTMLE.
N = 10 N = 100 N = 1000
greedy CTMLE 656.25 674.20 1308.75
SL-CTMLE 373.67 442.23 813.82
p = 10 p = 100 p = 1000
greedy CTMLE 2534.33 480,000.21 5829,613.59
SL-CTMLE 934.85 47,265.28 101,375.31
Table 3: Estimator time complexity benchmarks (in milliseconds) over
100 evaluations. When sample size N = 10, N = 100 and N = 1000, dimen-
sion p was fixed (p = 5). When p = 10, p = 100 and p = 1000, sample size
N was fixed (N = 100).
4 Results of Data Analysis
Table 4 to Table 6 report the average treatment effect (ATE), p-value and
95% confidence interval coverage of each blood product transfusion based
on predefined protocol. Table 4 reports hemostasis as the outcome. Table 5
and Table 6 report mortality at 6 hour and mortality at 24 hour as outcome
respectively. Platelet transfusion had 13% significant increase in hemostasis
(p < 0.01) in the on versus off-protocol, but no significant effect in either
mortality at 6h or mortality at 24h. Plasma transfusion showed significant
11% increase in hemostasis and 17% decrease in mortality at 6h (p<0.01)
but no significant effect in mortality at 24h. Cryoprecipitate transfusion
resulted in 20% increase in hemostasis and 16% decrease in mortality at 6h
(p<0.01) but no significant impact on mortality at 24h.
Treatment Adjusted ATE(95% CI) Unadjusted ATE
Platelet Protocol 0.133(0.0430, 0.223) 0.2005 (0.183,0.221)
Hemostasis Plasma Protocol 0.111(0.0914, 0.131) 0.09723 (0.0324,0.127)
Cryo Protocol 0.203(0.1042, 0.3009) 0.2418(0.1318,0.2845)
Platelet Protocol -0.1365(-0.3239, 0.0508) -0.1196(-0.3598,0.0357)
Mortality at 6h Plasma Protocol -0.1692(-0.2159, -0.1224) -0.2111(-0.3912,-0.1523)
Cryo Protocol -0.1584(-0.2347, -0.08216) -0.09389(-0.1456, 0.1721)
Platelet Protocol 0.00501( -0.2951, 0.3051) 0.02597(-0.0817,0.0945)
Mortality at 24h Plasma Protocol -0.07946 (-0.4196, 0.2606) -0.1476(-0.3128,0.4289)
Cryo Protocol 0.04573(-0.1912, 0.2827) 0.04367(-0.0815,0.1023)
Table 4: The ATE of each blood product transfusion with change in
hemostasis status as the outcome.Hemostasis is defined based on
transfusion of packed RBC (achieved hemostasis == 1), positive value
implies increase in the percentage of patients who achieved
hemostasis.Death == 1, Alive == 0, negative value implies decrease in
death rate
5 Discussion
The treatment protocol based on TEG showed significant improvement in
1671 trauma patient’s hemostasis status and decrease in mortality at 6h.
The effect of intervention on mortality at 24h is statistically insignificant
for all blood product transfusions. In the data used, there are insufficient
observations recorded after the first 6 hours to estimate the relative bene-
fits of being on protocol during later periods, for those patients not yet in
hemostasis. Between 6 hours to 24 hours, the intervention was possibly con-
founded by many other treatments received during the same time interval,
but the positivity and independence assumptions under causal framework
are no longer well-defined due to the sparsity of data between 6 and 24
hours. Although CTMLE is less prone to posivity bias, it can err on the
side of insufficient adjustment of real confounding if the sample size insuf-
ficient. In any case, it provides essentially as much adjustment as the data
will ”tolerate.”
The estimation of hemostasis and mortality at 6h as outcomes proves the
robustness of CTMLE under the high-dimensional, sparse data setting. Tra-
ditionally, doubly robust estimators relie on getting a consistent estimation
of either g0 or Q0 (ideally both) to construct a well-behaved estimator in an
asymptotic manner.17 Standard TMLE updates initial estimation of Q¯0 into
Q¯∗n based on estimator gn of g0. This method handles most of the estima-
tion problems well, but breaks down when the data is extremely sparse in
high dimensions.15 To achieve robust estimation even in high dimensions, we
optimized the construction step of gn by incorporating the idea of ”dimen-
sion reduction.” Instead of including all the covariates to build propensity
score model, we selected covariates based on a targeted loss function. The
additional selection step makes the estimation pipeline more sequential and
flexible in a data-driven manner.
To make the CTMLE procedure more computationally efficient, we add
an additional layer, ranking, to the selection step. The core idea is that
an ordered data structure generally reduces the computational complexity
on a large scale. The previous greedy selection algorithm has a second-
order time complexity. By pre-ranking the covariates, we could reduce the
time complexity to O(p), with p representing the dimension of covariates. 20
The pre-ordering step leaves room for further improvement. We would
like to select the most optimal pre-ordering algorithm. To achieve the goal,
we extended the pre-ordering step to a convex combination of learners in
learner library, which is called super learning.14 Super learning does not dis-
rupt the estimation step or the computational efficiency. Instead, it truly
makes the estimation procedures non parametric by letting the machine try
out all possible combinations of algorithms and eventually select the best
estimator using cross-validation.21
The current work focuses on analyzing whether the protocol has any
impact on trauma patient’s hemostasis and mortality. The future work will
extend to design the optimal treatment regime based on the scalable CTMLE
framework to find out if we can theoretically achieve better performance
than the current protocol. Also, the future work will extend the binary
treatment/outcome variables to continuous variables to make the estimator
even more data-driven and more adaptive in various practical settings.
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